Cargando…

Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension

BACKGROUND: Little is known about in vivo alterations at bronchial and vascular levels in severe pulmonary hypertension (PH) of different etiologies. We aimed to compare quantitative computed tomography (CT) data from the following three groups of severe precapillary PH patients: COPD, idiopathic pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Coste, Florence, Benlala, Ilyes, Dournes, Gaël, Dromer, Claire, Blanchard, Elodie, Girodet, Pierre-Olivier, Montaudon, Michel, Baldacci, Fabien, Picard, François, Marthan, Roger, Laurent, François, Berger, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377046/
https://www.ncbi.nlm.nih.gov/pubmed/30809092
http://dx.doi.org/10.2147/COPD.S177638
_version_ 1783395688637267968
author Coste, Florence
Benlala, Ilyes
Dournes, Gaël
Dromer, Claire
Blanchard, Elodie
Girodet, Pierre-Olivier
Montaudon, Michel
Baldacci, Fabien
Picard, François
Marthan, Roger
Laurent, François
Berger, Patrick
author_facet Coste, Florence
Benlala, Ilyes
Dournes, Gaël
Dromer, Claire
Blanchard, Elodie
Girodet, Pierre-Olivier
Montaudon, Michel
Baldacci, Fabien
Picard, François
Marthan, Roger
Laurent, François
Berger, Patrick
author_sort Coste, Florence
collection PubMed
description BACKGROUND: Little is known about in vivo alterations at bronchial and vascular levels in severe pulmonary hypertension (PH) of different etiologies. We aimed to compare quantitative computed tomography (CT) data from the following three groups of severe precapillary PH patients: COPD, idiopathic pulmonary arterial hypertension (iPAH), and chronic thromboembolic PH (CTEPH). PATIENTS AND METHODS: This study was approved by the institutional review board. Severe PH patients (mean pulmonary arterial pressure [mPAP] ≥35 mmHg) with COPD, iPAH, or CTEPH (n=24, 16, or 16, respectively) were included retrospectively between January 2008 and January 2017. Univariate analysis of mPAP was performed in each severe PH group. Bronchial wall thickness (WT) and percentage of cross sectional area of pulmonary vessels less than 5 mm(2) normalized by lung area (%CSA(<5)) were measured and compared using CT, and then combined to arterial partial pressure of oxygen (PaO(2)) to generate a “paw score” compared within the three groups using Kruskal–Wallis and its sensitivity using Fisher’s exact test. RESULTS: WT was higher and %CSA(<5) was lower in the COPD group compared to iPAH and CTEPH groups. Mosaic pattern was higher in CTEPH group than in others. In severe PH patients secondary to COPD, mPAP was positively correlated to %CSA(<5). By contrast, in severe iPAH, this correlation was negative, or not correlated in severe CTEPH groups. In the COPD group, “paw score” showed higher sensitivity than in the other two groups. CONCLUSION: Unlike in severe iPAH and CTEPH, severe PH with COPD can be predicted by “paw score” reflecting bronchial and vascular morphological differential alterations.
format Online
Article
Text
id pubmed-6377046
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63770462019-02-26 Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension Coste, Florence Benlala, Ilyes Dournes, Gaël Dromer, Claire Blanchard, Elodie Girodet, Pierre-Olivier Montaudon, Michel Baldacci, Fabien Picard, François Marthan, Roger Laurent, François Berger, Patrick Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Little is known about in vivo alterations at bronchial and vascular levels in severe pulmonary hypertension (PH) of different etiologies. We aimed to compare quantitative computed tomography (CT) data from the following three groups of severe precapillary PH patients: COPD, idiopathic pulmonary arterial hypertension (iPAH), and chronic thromboembolic PH (CTEPH). PATIENTS AND METHODS: This study was approved by the institutional review board. Severe PH patients (mean pulmonary arterial pressure [mPAP] ≥35 mmHg) with COPD, iPAH, or CTEPH (n=24, 16, or 16, respectively) were included retrospectively between January 2008 and January 2017. Univariate analysis of mPAP was performed in each severe PH group. Bronchial wall thickness (WT) and percentage of cross sectional area of pulmonary vessels less than 5 mm(2) normalized by lung area (%CSA(<5)) were measured and compared using CT, and then combined to arterial partial pressure of oxygen (PaO(2)) to generate a “paw score” compared within the three groups using Kruskal–Wallis and its sensitivity using Fisher’s exact test. RESULTS: WT was higher and %CSA(<5) was lower in the COPD group compared to iPAH and CTEPH groups. Mosaic pattern was higher in CTEPH group than in others. In severe PH patients secondary to COPD, mPAP was positively correlated to %CSA(<5). By contrast, in severe iPAH, this correlation was negative, or not correlated in severe CTEPH groups. In the COPD group, “paw score” showed higher sensitivity than in the other two groups. CONCLUSION: Unlike in severe iPAH and CTEPH, severe PH with COPD can be predicted by “paw score” reflecting bronchial and vascular morphological differential alterations. Dove Medical Press 2019-02-11 /pmc/articles/PMC6377046/ /pubmed/30809092 http://dx.doi.org/10.2147/COPD.S177638 Text en © 2019 Coste et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Coste, Florence
Benlala, Ilyes
Dournes, Gaël
Dromer, Claire
Blanchard, Elodie
Girodet, Pierre-Olivier
Montaudon, Michel
Baldacci, Fabien
Picard, François
Marthan, Roger
Laurent, François
Berger, Patrick
Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension
title Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension
title_full Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension
title_fullStr Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension
title_full_unstemmed Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension
title_short Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension
title_sort quantitative ct assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377046/
https://www.ncbi.nlm.nih.gov/pubmed/30809092
http://dx.doi.org/10.2147/COPD.S177638
work_keys_str_mv AT costeflorence quantitativectassessmentofbronchialandvascularalterationsinsevereprecapillarypulmonaryhypertension
AT benlalailyes quantitativectassessmentofbronchialandvascularalterationsinsevereprecapillarypulmonaryhypertension
AT dournesgael quantitativectassessmentofbronchialandvascularalterationsinsevereprecapillarypulmonaryhypertension
AT dromerclaire quantitativectassessmentofbronchialandvascularalterationsinsevereprecapillarypulmonaryhypertension
AT blanchardelodie quantitativectassessmentofbronchialandvascularalterationsinsevereprecapillarypulmonaryhypertension
AT girodetpierreolivier quantitativectassessmentofbronchialandvascularalterationsinsevereprecapillarypulmonaryhypertension
AT montaudonmichel quantitativectassessmentofbronchialandvascularalterationsinsevereprecapillarypulmonaryhypertension
AT baldaccifabien quantitativectassessmentofbronchialandvascularalterationsinsevereprecapillarypulmonaryhypertension
AT picardfrancois quantitativectassessmentofbronchialandvascularalterationsinsevereprecapillarypulmonaryhypertension
AT marthanroger quantitativectassessmentofbronchialandvascularalterationsinsevereprecapillarypulmonaryhypertension
AT laurentfrancois quantitativectassessmentofbronchialandvascularalterationsinsevereprecapillarypulmonaryhypertension
AT bergerpatrick quantitativectassessmentofbronchialandvascularalterationsinsevereprecapillarypulmonaryhypertension